In particular, pulmonary hypertension (PH) related to CVD (Group II PH) may be an optimal target for metformin therapy. The objective of this review article is to provide an overview of the ...

Tectonic Therapeutic said the findings support the design and population for Phase 2 APEX trial, which will test TX45 in ...

Pulmonary arterial hypertension (PAH) is commonly associated with congenital heart disease (CHD) and relates to type of the underlying cardiac defects and repair history. Large systemic to pulmonary ...

Eko Health developed an AI algorithm that, combined with noninvasive heart tests, may be able to accurately identify pulmonary hypertension.

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

11, 2025 — Patients aged between 50 to 70 years with a mechanical heart valve replacement ... Approach Identifies Early Signs of Pulmonary Arterial Hypertension Jan. 22, 2025 — A new molecular ...

India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

This February, Morris-Simon and her colleagues at Bayer are leveraging Heart Month and Black History Month as an opportunity to underscore Bayer’s commitment to heart health and to raise awareness ...

Pulmonary arterial hypertension is a disease of the pulmonary vasculature, resulting in elevated pressure in the pulmonary arteries and disrupting the physiological coordination between the right ...

Chronic thromboembolic pulmonary hypertension occurs in a proportion of patients with prior acute pulmonary embolism and is characterised by breathlessness, persistently raised pulmonary pressures and ...

Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...